Literature DB >> 9860024

Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis.

M S Dykewicz1, S Fineman.   

Abstract

Rhinitis is a significant cause of widespread morbidity, medical treatment costs, reduced work productivity and lost school days. Although sometimes mistakenly viewed as a trivial disease, symptoms of allergic and non-allergic rhinitis may significantly impact a patient's quality of life, by causing fatigue, headache, cognitive impairment and other systemic symptoms. In addition, many antihistamines commonly used for treatment can themselves cause performance impairment that may contribute to fatal automobile accidents, work place accidents, decreased work productivity and in children, impaired school performance. Appropriate management of rhinitis may be an important component in effective management of coexisting or complicating respiratory conditions, such as asthma, sinusitis, or chronic otitis media. Rhinitis may be caused by allergic, non-allergic, infectious, hormonal, occupational, and other factors. Defining the causes of rhinitis in an individual is important because different rhinitis syndromes may require different therapeutic approaches for optimal management, an important consideration as more treatment options become available. This Executive Summary reviews key points about diagnosis and management of rhinitis contained in the comprehensive document, Diagnosis and Management of Rhinitis: Complete Guidelines of Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology, and Joint Task Force Algorithm and Annotations for Diagnosis and Management of Rhinitis. These documents represent a consensus opinion of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology, a national panel co-sponsored by the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council on Allergy, Asthma and Immunology.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9860024     DOI: 10.1016/S1081-1206(10)63152-3

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  35 in total

Review 1.  Human nasal allergen provocation for determination of true allergic rhinitis: methods for clinicians.

Authors:  Ludmila I Litvyakova; James N Baraniuk
Journal:  Curr Allergy Asthma Rep       Date:  2002-05       Impact factor: 4.806

Review 2.  Intranasal corticosteroids for allergic rhinitis: superior relief?

Authors:  L P Nielsen; N Mygind; R Dahl
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Qualitative Development of the Rhinitis Control Assessment Test (RCAT), an Instrument for Evaluating Rhinitis Symptom Control.

Authors:  Robert A Nathan; Anand A Dalal; Richard H Stanford; Eli O Meltzer; Michael Schatz; Jennifer Derebery; Matthew Mintz; Michelle A Thompson; Dana B Dibenedetti
Journal:  Patient       Date:  2010-06-01       Impact factor: 3.883

4.  Does allergic rhinitis affect communication skills in young adults?

Authors:  Can Cemal Cingi; Öner Sakallıoğlu; Nuray Bayar Muluk; Cemal Cingi
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-03       Impact factor: 2.503

Review 5.  Ebastine: an update of its use in allergic disorders.

Authors:  M Hurst; C M Spencer
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

Review 6.  The cost of treating allergic rhinitis.

Authors:  David A Stempel; Roger Woolf
Journal:  Curr Allergy Asthma Rep       Date:  2002-05       Impact factor: 4.806

Review 7.  Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies.

Authors:  G W Canonica; E Compalati
Journal:  Clin Exp Immunol       Date:  2009-08-25       Impact factor: 4.330

8.  Skin prick test reactivity to common aeroallergens and ARIA classification of allergic rhinitis in patients of Central Greece.

Authors:  K K Anastassakis; A Chatzimichail; I Androulakis; S Charisoulis; Maria Riga; Anna Eleftheriadou; V Danielides
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-01       Impact factor: 2.503

Review 9.  Patient adherence to allergic rhinitis treatment: results from patient surveys.

Authors:  Erkka Valovirta; Dermot Ryan
Journal:  Medscape J Med       Date:  2008-10-28

10.  Desloratadine therapy improves allergic rhinitis symptoms in latin american children aged 6 to 12 years.

Authors:  Paolo Tassinari; Nelson R Suárez; Jorge Centeno; Janina Vergara Velásquez; Héctor Aguirre-Mariscal; Sandra N Gonzálezdíaz; Alfredo Fernández de Córdova Jerves
Journal:  World Allergy Organ J       Date:  2009-04       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.